Literature DB >> 67888

A collaborative clinical study of carcinoembryonic antigen in Japan.

H Hirai.   

Abstract

A radioimmunoassay for carcinoembryonic antigen with utilization of the so-called sandwich method was established and used for clinical investigation. A collaborative study was made through the cooperation of 34 institutions in Japan, and serum samples from about 400 normal adults, 500 patients with benign diseases, and 1500 cancer patients were assayed. About 90% of the normal adults showed carcinoembryonic antigen levels of under 2.5 ng/ml. The benign disease group showed somewhat higher levels than did the normal group, and the cancer group had levels significantly higher than those of the benign group. The levels were strikingly high in cases of advanced cancer with metastases. The specificity of carcinoembryonic antigen and its antiserum is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 67888

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Serum CEA levels facilitate detection of recurrences of cancer in patients after gastrectomy.

Authors:  R Tamada; Y Hiramoto; S Tsujitani; T Nozuka; T Okamura; H Masuda; K Sugimachi; K Inokuchi
Journal:  Jpn J Surg       Date:  1985-01

2.  [Demonstration of circulating CEA or CEA-like antigens and immunoglobulin G containing immune complexes in colorectal carcinoma].

Authors:  R Pompecki
Journal:  Klin Wochenschr       Date:  1984-04-02

3.  Identification of carcinoembryonic antigen (CEA) in bile of patients with malignant biliary tract disease.

Authors:  K Konomi; K Nakamura; M Tobimatsu; S Saito; K Toyoda; Y Yasunami
Journal:  Jpn J Surg       Date:  1982

4.  Serial determinations of carcinoembryonic antigen for early detection of recurrent gastric cancer.

Authors:  R Tamada; Y Hiramoto; Y Abe; T Nouzuka; T Okamura; H Masuda; T Kano; R Kumashiro; K Inokuchi
Journal:  Jpn J Surg       Date:  1982

5.  Immunoreactive carcinoembryonic antigen [CEA] levels in feces from colorectal cancer patients.

Authors:  Y Kitsukawa
Journal:  Jpn J Surg       Date:  1979-06

6.  Serum tumor markers in patients with hepatocellular carcinoma: diagnosis of alpha-fetoprotein -low or -negative patients.

Authors:  N Sawabu; T Wakabayashi; K Ozaki; D Toya; M Yoneshima; H Kidani; N Hattori; M Ishii
Journal:  Gastroenterol Jpn       Date:  1985-06

7.  Carcinoembryonic antigen (CEA) in gastric juice or feces as an aid in the diagnosis of gastrointestinal cancer.

Authors:  S Fujimoto; U Kitsukawa; K Itoh
Journal:  Ann Surg       Date:  1979-01       Impact factor: 12.969

8.  Radioimmunoassay for carcinoembryonic antigen and alpha 1-fetoprotein in the qualitative evaluation of focal hepatic lesions in Japan.

Authors:  T Aburano; N Tonami; A Tada; K Hisada
Journal:  Eur J Nucl Med       Date:  1980-08

9.  Further investigations of immunoreactive carcinoembryonic antigen (CEA) in colorectal cancer patients--with particular emphasis on the correlation between immunoreactive CEA levels in tissue, feces and blood.

Authors:  S Fujimoto; Y Kitsukawa
Journal:  Jpn J Surg       Date:  1981-01

10.  Prognostic significance of serum and tissue carcinoembryonic antigen in patients with gastric adenocarcinomas.

Authors:  Seong-Hoon Park; Ki-Beom Ku; Ho-Young Chung; Wansik Yu
Journal:  Cancer Res Treat       Date:  2008-03-31       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.